X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1794) 1794
male (1307) 1307
female (1210) 1210
index medicus (1167) 1167
liver neoplasms - therapy (1167) 1167
middle aged (1147) 1147
aged (1019) 1019
carcinoma, hepatocellular - therapy (978) 978
chemoembolization, therapeutic - adverse effects (924) 924
hepatocellular carcinoma (847) 847
treatment outcome (847) 847
adult (682) 682
liver neoplasms - pathology (612) 612
transarterial chemoembolization (580) 580
oncology (567) 567
chemoembolization, therapeutic - methods (564) 564
carcinoma, hepatocellular - pathology (536) 536
transcatheter arterial chemoembolization (524) 524
liver neoplasms - mortality (502) 502
retrospective studies (496) 496
liver cancer (485) 485
cancer (473) 473
chemoembolization (472) 472
gastroenterology & hepatology (472) 472
survival (437) 437
carcinoma, hepatocellular - mortality (436) 436
radiology, nuclear medicine & medical imaging (432) 432
hepatoma (417) 417
aged, 80 and over (387) 387
embolization (373) 373
care and treatment (369) 369
liver (347) 347
chemotherapy (340) 340
liver neoplasms - drug therapy (338) 338
risk factors (316) 316
time factors (292) 292
survival rate (282) 282
carcinoma, hepatocellular - drug therapy (280) 280
chemoembolization, therapeutic (271) 271
therapy (265) 265
surgery (258) 258
tumors (254) 254
neoplasm staging (250) 250
prognosis (250) 250
antineoplastic agents - administration & dosage (247) 247
tomography, x-ray computed (243) 243
hepatocellular-carcinoma (235) 235
management (235) 235
radiofrequency ablation (234) 234
combined modality therapy (230) 230
sorafenib (225) 225
microspheres (214) 214
kaplan-meier estimate (211) 211
liver neoplasms - secondary (211) 211
survival analysis (207) 207
patients (196) 196
antineoplastic agents - therapeutic use (192) 192
doxorubicin - administration & dosage (192) 192
antineoplastic agents - adverse effects (190) 190
liver neoplasms - surgery (188) 188
liver neoplasms - diagnostic imaging (187) 187
follow-up studies (175) 175
hepatic artery (171) 171
medicine & public health (165) 165
carcinoma, hepatocellular - surgery (163) 163
efficacy (161) 161
radiology (161) 161
prospective studies (160) 160
disease-free survival (158) 158
niacinamide - analogs & derivatives (155) 155
peripheral vascular disease (155) 155
embolization, therapeutic - adverse effects (153) 153
metastasis (153) 153
chemoembolization, therapeutic - mortality (146) 146
cirrhosis (146) 146
carcinoma, hepatocellular - diagnostic imaging (145) 145
randomized controlled trial (145) 145
proportional hazards models (144) 144
embolization, therapeutic - methods (143) 143
tace (142) 142
health aspects (137) 137
analysis (136) 136
resection (135) 135
liver neoplasms - radiotherapy (134) 134
radiotherapy (133) 133
liver neoplasms - complications (131) 131
cancer therapies (130) 130
digestive system diseases (129) 129
carcinoma, hepatocellular - complications (127) 127
complications (125) 125
doxorubicin (125) 125
disease progression (124) 124
multivariate analysis (124) 124
medical prognosis (121) 121
research (119) 119
antibiotics, antineoplastic - administration & dosage (116) 116
usage (115) 115
infusions, intra-arterial (113) 113
safety (110) 110
hepatectomy (109) 109
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1989) 1989
Chinese (46) 46
Japanese (27) 27
German (18) 18
Korean (11) 11
French (8) 8
Italian (7) 7
Spanish (5) 5
Russian (3) 3
Hungarian (2) 2
Polish (2) 2
Czech (1) 1
Danish (1) 1
Hebrew (1) 1
Icelandic (1) 1
Portuguese (1) 1
Romanian (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Gastroenterology, ISSN 0016-5085, 2016, Volume 151, Issue 6, pp. 1155 - 1163.e2
Journal Article
Gastroenterology, ISSN 0016-5085, 2011, Volume 140, Issue 2, pp. 497 - 507.e2
Journal Article
世界胃肠病学杂志:英文版, ISSN 1007-9327, 2015, Volume 21, Issue 12, pp. 3462 - 3471
Management of hepatocellular carcinoma(HCC) with portal vein thrombosis(PVT) is complex andrequires an understanding of multiple therapeutic options. PVT is... 
Hepatocellular | vein | thrombosis;Yt | carcinoma;Portal | Hepatocellular carcinoma | Selective internal radiation therapy | Management | Portal vein thrombosis | Yttrium 90 | FATTY LIVER-DISEASE | TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION | LONG-TERM OUTCOMES | PHASE-III | Y-90 GLASS MICROSPHERES | NATURAL-HISTORY | TUMOR THROMBOSIS | RADIATION-THERAPY | EXTERNAL-BEAM RADIOTHERAPY | CONCURRENT TRANSARTERIAL CHEMOEMBOLIZATION | GASTROENTEROLOGY & HEPATOLOGY | Niacinamide - analogs & derivatives | Venous Thrombosis - diagnosis | Carcinoma, Hepatocellular - mortality | Liver Transplantation | Humans | Liver Neoplasms - complications | Antineoplastic Agents - therapeutic use | Liver Neoplasms - therapy | Protein Kinase Inhibitors - adverse effects | Liver Neoplasms - mortality | Portal Vein | Contraindications | Carcinoma, Hepatocellular - complications | Antineoplastic Agents - adverse effects | Phenylurea Compounds - adverse effects | Liver Neoplasms - pathology | Venous Thrombosis - therapy | Niacinamide - adverse effects | Venous Thrombosis - mortality | Niacinamide - therapeutic use | Phenylurea Compounds - therapeutic use | Treatment Outcome | Chemoembolization, Therapeutic - mortality | Venous Thrombosis - etiology | Protein Kinase Inhibitors - therapeutic use | Carcinoma, Hepatocellular - pathology | Chemoembolization, Therapeutic - adverse effects | Carcinoma, Hepatocellular - therapy | Radiopharmaceuticals - adverse effects | Radiopharmaceuticals - therapeutic use | Practice Guidelines as Topic | Review
Journal Article
Journal Article
Journal of Vascular and Interventional Radiology, ISSN 1051-0443, 2016, Volume 27, Issue 4, pp. 457 - 473
Journal Article
HPB, ISSN 1365-182X, 01/2015, Volume 17, Issue 1, pp. 29 - 37
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2012, Volume 56, Issue 6, pp. 1336 - 1342
Journal Article